Symphogen
Presence
Laboratoire Servier has 3 subsidiaries including Biogaran, Servier Pharmaceuticals and Symphogen.
They are in:
- Pharmaceuticals75%
- Biotechnology25%
Executives
View the org chart displaying its 8 main executives
Most searched biographies at Symphogen
- Christophe Thurieau, Chief Executive Officer and Director
- Benoit Cheron, Director
- Claude Bertrand, Chairman of the Board
Popular executive movements at Laboratoire Servier
- Nicolas Garnier has joined the company as Chief Patient Officer (posted on December 18 2023).
- Cécile Ribot has joined the company as Human Resources Director (posted on November 16 2023).
Create your alert
to follow the executive moves at Symphogen.
Biotechnology
Laboratoire Servier has 2,274 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by Symphogen
Social media about Symphogen
- Symphogen on Wikipedia, Google News & Yahoo Finance
- Symphogen on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Claude Bertrand 
